The Duke Translational Research Institute’s mission is to rapidly and effectively invent, develop, and test new drugs, diagnostics, and devices for human use. DTRI, headed by Dr. Bruce Sullenger, provides guidance from experienced leadership, critical resources, and infrastructure for academic translational researchers.

DTRI Technology Cores

• Cell Therapy
  Contact Rebecca Haley, MD (rebecca.haley@duke.edu / 919.668.8644)
• Clinical Vaccine Unit
  Contact: Lynn Sutton (lynn.sutton@duke.edu / 919.668.8925)
• Imaging
  Contact: Brian Reynolds (brian.reynolds@duke.edu / 919.668.8370)
• Immune Monitoring
  Contact: Lynn Sutton (lynn.sutton@duke.edu / 919.668.8925)
• -Omics
  Contact: Jessie Tenenbaum (jessie.tenenbaum@duke.edu / 919 668 8811)

Collaborations between the 'bench' scientists and the clinical researchers of the Duke Clinical Research Institute will allow cross-analysis access to early phases of development in these areas to plan how to bring discoveries forward to be useful to patients.